| Primary |
| Product Used For Unknown Indication |
57.9% |
| Back Pain |
31.6% |
| Pain |
10.5% |
|
| Poisoning |
54.4% |
| Self-medication |
13.2% |
| Respiratory Arrest |
10.3% |
| Toxicity To Various Agents |
7.4% |
| Poisoning Deliberate |
2.9% |
| Bedridden |
1.5% |
| Inadequate Analgesia |
1.5% |
| Nausea |
1.5% |
| Potentiating Drug Interaction |
1.5% |
| Refusal Of Treatment By Patient |
1.5% |
| Secondary Hypogonadism |
1.5% |
| Somnolence |
1.5% |
| Unresponsive To Stimuli |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
25.0% |
| Lung Adenocarcinoma |
9.1% |
| Neuralgia |
9.1% |
| Pain |
9.1% |
| Cancer Pain |
8.0% |
| Bipolar Disorder |
6.8% |
| Myelitis Transverse |
6.8% |
| Major Depression |
4.5% |
| Prophylaxis |
4.5% |
| Drug Withdrawal Syndrome Neonatal |
2.3% |
| Foetal Exposure During Pregnancy |
2.3% |
| Non-small Cell Lung Cancer |
2.3% |
| Transitional Cell Carcinoma |
2.3% |
| Analgesic Therapy |
1.1% |
| Breakthrough Pain |
1.1% |
| Cough |
1.1% |
| Hypertension |
1.1% |
| Investigation |
1.1% |
| Metastatic Malignant Melanoma |
1.1% |
| Pain In Hip |
1.1% |
|
| Poisoning |
36.6% |
| Drug Withdrawal Syndrome |
9.8% |
| Overdose |
4.9% |
| Pyrexia |
4.9% |
| Respiratory Arrest |
4.9% |
| Toxicity To Various Agents |
4.9% |
| Venoocclusive Liver Disease |
4.9% |
| Vomiting |
4.9% |
| Drug Dependence |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Maternal Drugs Affecting Foetus |
2.4% |
| Nausea |
2.4% |
| Necrotising Colitis |
2.4% |
| Self-medication |
2.4% |
| Sinus Tachycardia |
2.4% |
| Small Intestinal Obstruction |
2.4% |
| Somnolence |
2.4% |
| Weight Bearing Difficulty |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
57.9% |
| Pain |
10.7% |
| Pilonidal Cyst |
5.0% |
| Depression |
2.9% |
| Drug Use For Unknown Indication |
2.7% |
| Analgesic Therapy |
2.6% |
| Rheumatoid Arthritis |
2.3% |
| Hypertension |
2.0% |
| Back Pain |
1.6% |
| B-cell Lymphoma |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.3% |
| Constipation |
1.3% |
| Prophylaxis |
1.3% |
| Acute Myeloid Leukaemia |
1.2% |
| Oral Candidiasis |
1.2% |
| Mantle Cell Lymphoma |
1.0% |
| Nausea |
1.0% |
| Non-small Cell Lung Cancer Stage Iiia |
1.0% |
| Multiple Myeloma |
0.9% |
| Premedication |
0.9% |
|
| Vertigo |
14.7% |
| Tremor |
10.7% |
| Rheumatoid Arthritis |
8.0% |
| Thrombocytopenia |
8.0% |
| Fall |
6.7% |
| Sepsis |
6.7% |
| Bradycardia |
5.3% |
| Death |
4.0% |
| Optic Neuritis |
4.0% |
| Rash Generalised |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Disease Progression |
2.7% |
| International Normalised Ratio Increased |
2.7% |
| Nausea |
2.7% |
| Paraesthesia |
2.7% |
| Platelet Count Increased |
2.7% |
| Swelling Face |
2.7% |
| Tonsillar Ulcer |
2.7% |
| Urinary Tract Infection |
2.7% |
| Visual Acuity Reduced |
2.7% |
|
| Interacting |
| Pain |
40.0% |
| Anxiety |
10.0% |
| Arrhythmia |
10.0% |
| Depressed Mood |
10.0% |
| Meniere's Disease |
10.0% |
| Prophylaxis |
10.0% |
| Prostatic Disorder |
10.0% |
|
| Withdrawal Syndrome |
100.0% |
|
